Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"

Jagdeep S. Singh; Allan D. Struthers; Chim C. Lang

doi:10.1161/CIRCULATIONAHA.120.053057

Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"

Jagdeep S. Singh, Allan D. Struthers, Chim C. Lang (Lead / Corresponding author)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e38-e39
Journal	Circulation
Volume	144
Issue number	3
Early online date	19 Jul 2021
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.120.053057
Publication status	Published - 20 Jul 2021

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/CIRCULATIONAHA.120.053057

Cite this

@article{198b1b30ce744a15ac565f2fb1c124ba,

title = "Letter by Singh et al Regarding Article, {"}Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF){"}",

author = "Singh, {Jagdeep S.} and Struthers, {Allan D.} and Lang, {Chim C.}",

year = "2021",

month = jul,

day = "20",

doi = "10.1161/CIRCULATIONAHA.120.053057",

language = "English",

volume = "144",

pages = "e38--e39",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)". / Singh, Jagdeep S.; Struthers, Allan D.; Lang, Chim C. (Lead / Corresponding author).
In: Circulation, Vol. 144, No. 3, 20.07.2021, p. e38-e39.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"

AU - Singh, Jagdeep S.

AU - Struthers, Allan D.

AU - Lang, Chim C.

PY - 2021/7/20

Y1 - 2021/7/20

UR - http://www.scopus.com/inward/record.url?scp=85111021525&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.120.053057

DO - 10.1161/CIRCULATIONAHA.120.053057

M3 - Letter

C2 - 34279989

SN - 0009-7322

VL - 144

SP - e38-e39

JO - Circulation

JF - Circulation

IS - 3

ER -

Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

PRecision Medicine for Diabetis Individuals: a Joint Malaysia-UK Effort (PRIME) - (Joint with UMBI)

REnal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop DiurEtics in Diabetic Patients with Chronic Heart Failure (RECEDE-CHF)

Cite this

Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Projects

PRecision Medicine for Diabetis Individuals: a Joint Malaysia-UK Effort (PRIME) - (Joint with UMBI)

REnal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop DiurEtics in Diabetic Patients with Chronic Heart Failure (RECEDE-CHF)

Cite this